Category: Cost Alert

Pricey Hep C Drugs to Blame for Higher Health Care Spending

Gilead’s Solvaldi and Harvoni – which ring in price tags at $1,000 or more per pill – were leading culprits behind the 12.6 percent prescription drug spending increase in 2014. Continue reading

Posted in: Cost Alert

Improper patents lead to substantially higher drug costs

The problem of wrongly granted patents leads to higher prices for patients, small and large employers, Medicare, and Medicaid – not to mention billions of dollars of “pure economic waste,” according to a new report from the Center for Economic and Policy Research. Continue reading

Posted in: Cost Alert

Durham Op-Ed: “The Great Threat of Rising Health Care Costs”

Today’s Morning Consult features an op-ed by AHIP Interim CEO Dan Durham, in which he states now is the time to focus on ensuring health care accessibility, affordability, and quality. However, Durham highlights underlying challenges that all stakeholders need to confront in order to move the health system forward. Continue reading

Posted in: AHIP in the News, Cost Alert

Striking down weak patents protects patients

In some cases, explosive drug prices are the result of drugmakers’ patent schemes that financially distress consumers and limit their treatment options. That is why a recent proposal to exempt pharmaceutical companies from a key consumer protection would leave families across the country even more hostage to egregious pharmaceutical prices. Continue reading

Posted in: AHIP Letters, Cost Alert

Hill Briefing Examines the Truth About Premiums

Influential factors that go into premiums took center stage this afternoon at a Capitol Hill briefing hosted by centrist think tank Third Way. The panelists all emphasized the fact that proposed premiums vary greatly; and therefore, it’s crucial to consider the full picture when looking at changes in premiums. Continue reading

Posted in: Cost Alert, On The Hill

Studies, experts agree: Provider consolidation drives up the cost of care

Here’s where it’s important to understand that insurance premiums track the underlying cost of medical care, like the cost of doctor’s visits, hospital stays, and prescription medications. So as the costs of medical care increase, so do premiums. One explanation for increases in hospital prices is consolidation among hospitals and other providers. Continue reading

Posted in: Cost Alert

Loud and Clear

Consumers are sending a strong message that drugmakers should hear loud and clear — prescription drug costs are unreasonable, according to the latest Kaiser Health Tracking Poll. Continue reading

Posted in: Cost Alert

Health Affairs Examines Exceptionally High Hospital Prices

Hospitals are charging exorbitant prices for services, and those markups continue to make health care coverage more expensive for everyone, according to a study published Monday in the journal Health Affairs. Continue reading

Posted in: Cost Alert

You’re Invited: Join our panel discussion on the Rx cost conundrum

This panel discussion will bring together stakeholders from various perspectives to discuss the challenges ahead and what can be done to encourage medical innovation while ensuring patients can access and afford the treatments they need. Continue reading

Posted in: Cost Alert, Issue Alert

CHART OF THE DAY: Cost of cancer drugs vs. oncology services

This week the Centers for Medicare and Medicaid Services released data that shows spending on cancer drugs in 2013 was more than twice as high as spending on other oncology services, CQ Roll Call reported. The numbers also drive home the unfortunate fact that sky’s-the-limit prices put lifesaving cancer medicines further and further out of reach for those who need them. Continue reading

Posted in: Cost Alert